International Biotechnology Trust’s Guardant Health GH Stock Holding History

International Biotechnology Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.08M	Hold	36,500	–	–	0.36%	50
2023 Q2	$1.31M	Sell	36,500 -38,000	-51%	-$1.09M	0.4%	43
2023 Q1	$1.75M	Hold	74,500	–	–	0.49%	43
2022 Q4	$2.02M	Hold	74,500	–	–	0.63%	35
2022 Q3	$4M	Buy	74,500 +71,495	+2,379%	+$3.67M	1.28%	26
2022 Q2	$74.5K	Sell	3,005 -71,495	-96%	-$3.54M	0.78%	31
2022 Q1	$271K	Hold	74,500	–	–	0.06%	66
2021 Q4	$7.45M	Buy	74,500 +38,000	+104%	+$3.93M	1.66%	24
2021 Q3	$4.56M	Buy	36,500 +19,500	+115%	+$2.32M	1.1%	27
2021 Q2	$2.11M	Buy	+17,000	New	+$2.29M	0.56%	39

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

International Biotechnology Trust's GH Position: Q3 2023 in Review

International Biotechnology Trust held its Guardant Health (GH) position steady in Q3 2023 at 36,500 shares worth $1.08M. The position accounts for 0.36% of the portfolio, ranked #50.

International Biotechnology Trust first reported a position in GH in Q2 2021 and has held it in 10 quarters since. The position peaked at $7.45M in Q4 2021. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

International Biotechnology Trust held 36,500 shares of Guardant Health worth $1.08M as of Q3 2023.
International Biotechnology Trust left its Guardant Health share count unchanged in Q3 2023.
Guardant Health made up 0.36% of International Biotechnology Trust's portfolio in Q3 2023, its #50 holding.
International Biotechnology Trust first reported a position in Guardant Health in Q2 2021 and has held it in 10 quarters since.
International Biotechnology Trust's Guardant Health position peaked at $7.45M in Q4 2021.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.